Sham Mailankody, MBBS | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Sham Mailankody, MBBS

Sham Mailankody, MBBS

Healthcare Professional
Oncologist - Hematologist
Memorial Sloan Kettering Commack
650 Commack Road
Commack, New York, United States
Sham Mailankody is a medical oncologist and hematologist at Memorial Sloan Kettering Cancer Center specializing in the care of people with multiple myeloma and related plasma cell disorders. He completed his MBBS from K.S. Hegde Medical Academy followed by residencies in internal medicine from Georgetown University/Washington Hospital Center and fellowships in medical oncology from National Cancer Institute. Dr Mailankody is board certified in medical oncology and internal medicine.
 
With his colleagues at Memorial Sloan Kettering Cancer Center, Sham Mailankody is focused on identifying optimal treatment strategies for people with these disorders and is interested in the molecular pathways underlying progression of plasma cell disorders and the development of targeted strategies aiming to delay, prevent, and cure full-blown disease. He also has an interest in health policy as it relates to oncologic drug approvals and the cost of cancer care.
 
 
Representative Publications:
 
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close